BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 11677377)

  • 1. Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone.
    Waeber B; Aschwanden R; Sadecky L; Ferber P
    J Hypertens; 2001 Nov; 19(11):2097-104. PubMed ID: 11677377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy.
    Mallion JM; Carretta R; Trenkwalder P; Martinez JF; Tykarski A; Teitelbaum I; Oddou P; Fagan T;
    Blood Press Suppl; 2003 May; 1():36-43. PubMed ID: 12800986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension.
    Wellington K; Faulds DM
    Drugs; 2002; 62(13):1983-2005. PubMed ID: 12215069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake.
    Weir MR; Smith DH; Neutel JM; Bedigian MP
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):665-71. PubMed ID: 11465651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies.
    Nash DT; Crikelair N; Zappe D
    Curr Med Res Opin; 2008 Sep; 24(9):2617-26. PubMed ID: 18687165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension.
    Stergiou GS; Skeva II; Baibas NM; Roussias LG; Kalkana CB; Achimastos AD; Mountokalakis TD
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):937-41. PubMed ID: 10836730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension.
    Chrysant SG; Fagan T; Glazer R; Kriegman A
    Arch Fam Med; 1996 Jan; 5(1):17-24; discussion 25. PubMed ID: 8542050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.
    Jacobsen P; Andersen S; Jensen BR; Parving HH
    J Am Soc Nephrol; 2003 Apr; 14(4):992-9. PubMed ID: 12660333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension.
    Palatini P; Malacco E; Fogari R; Carretta R; Bonaduce D; Bertocchi F; Mann J; Condorelli M;
    J Hypertens; 2001 Sep; 19(9):1691-6. PubMed ID: 11564991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
    Pool JL; Glazer R; Crikelair N; Levy D
    Clin Drug Investig; 2009; 29(12):791-802. PubMed ID: 19888785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study.
    Klingbeil AU; John S; Schneider MP; Jacobi J; Weidinger G; Schmieder RE
    J Hypertens; 2002 Dec; 20(12):2423-8. PubMed ID: 12473867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study.
    Malacco E; Santonastaso M; Varì NA; Gargiulo A; Spagnuolo V; Bertocchi F; Palatini P;
    Clin Ther; 2004 Jun; 26(6):855-65. PubMed ID: 15262456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of benazepril and other antihypertensive agents alone and in combination with the diuretic hydrochlorothiazide.
    DeQuattro V
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV28-32; discussion IV51-5. PubMed ID: 1893639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.